Craig Vargo

T-DM1 Activity in Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancers That Received Prior Therapy With Trastuzumab and Pertuzumab

Hannah Dzimitrowicz, Michael Berger, Craig Vargo et al. · Journal of Clinical Oncology · 2016 · 84 citations · Full text

Medicine, Oncology, Pharmacology +17

Progression-Free Survival for Real-World Use of Palbociclib in Hormone Receptor-Positive Metastatic Breast Cancer

Jonathan Wilkie, M. Alexandra Schickli, Michael Berger et al. · Clinical Breast Cancer · 2019 · 47 citations

Medicine, Oncology, Pharmacology +16

Prophylaxis with Sirolimus and Tacrolimus ± Antithymocyte Globulin Reduces the Risk of Acute Graft-versus-Host Disease without an Overall Survival Benefit Following Allogeneic Stem Cell Transplantation

Lindsay Rosenbeck, Patrick J. Kiel, Iftekhar Kalsekar et al. · Biology of Blood and Marrow Transplantation · 2010 · 32 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction

Michael Berger, Craig Vargo, M J Vincent et al. · Supportive Care in Cancer · 2014 · 28 citations · Full text

Medicine, Oncology, Pharmacology +14

An Antimicrobial Stewardship Program's Real‐World Experience with Fidaxomicin for Treatment of <i>Clostridium difficile</i> Infection: A Case Series

Craig Vargo, Karri A. Bauer, Julie E. Mangino et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2014 · 19 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17